{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T01:43:24Z","timestamp":1771811004274,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ejso.2019.01.009","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T12:46:33Z","timestamp":1547037993000},"page":"666-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO)"],"prefix":"10.1016","volume":"45","author":[{"given":"Aditi","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snita","family":"Sinukumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileep","family":"Damodaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabber","family":"Zaveri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Kammar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suniti","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loma","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Ranade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasanth","family":"Penumadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firoz","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejso.2019.01.009_bib1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s13193-016-0501-9","article-title":"The role of cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in ovarian cancer: a review","volume":"7","author":"Bhatt","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"Issue Suppl_8","key":"10.1016\/j.ejso.2019.01.009_bib2","article-title":"Optimal assessment of response in ovarian cancer","volume":"22","author":"Eisenhauer","year":"2011","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.01.009_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4251\/wjgo.v2.i1.12","article-title":"Pathophysiology and biology of peritoneal carcinomatosis","volume":"2","author":"Kusamura","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ygyno.2012.11.007","article-title":"Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?","volume":"128","author":"Hynninen","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib5","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","article-title":"Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study","volume":"19","author":"Baratti","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejso.2019.01.009_bib7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2019.01.009_bib8","article-title":"Pharmacokinetic study of perioperative intravenous ifosfamide","volume":"2011","author":"Van der Speeten","year":"2011","journal-title":"Int J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib9","series-title":"Management of peritoneal metastases- cytoreductive surgery, HIPEC and beyond","first-page":"389","article-title":"Early postoperative intraperitoneal chemotherapy: current role and future perspectives","author":"Douchy","year":"2018"},{"issue":"6","key":"10.1016\/j.ejso.2019.01.009_bib10","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","article-title":"A\u00a0new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy stage evaluation (PROMISE) application","volume":"42","author":"Villeneuve","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib11","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2014.60.5212","article-title":"Chemotherapy response score: development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma","volume":"33","author":"B\u00f6hm","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.01.009_bib12","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.3802\/jgo.2017.28.e73","article-title":"External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma","volume":"28","author":"Lee","year":"2017","journal-title":"J\u00a0Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/IGC.0b013e3182070f17","article-title":"Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Inter- group (GCIG)","volume":"21","author":"Rustin","year":"2011","journal-title":"Int J Gynecol Canc"},{"issue":"6","key":"10.1016\/j.ejso.2019.01.009_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.06.034","article-title":"Prognostic role and predictors of complete pathologic response to neoadjuvant chemotherapy in primary unresectable ovarian cancer","volume":"211","author":"Petrillo","year":"2014","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2019.01.009_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40944-017-0148-7","article-title":"Cytoreductive surgery and HIPEC in the first-line and interval time points of advanced epithelial ovarian cancer","volume":"15","author":"Kusamura","year":"2017","journal-title":"Indian J Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib16","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.ygyno.2006.06.025","article-title":"Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis","volume":"103","author":"Bristow","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2019.01.009_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000313823","article-title":"Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer","volume":"33","author":"Lim","year":"2010","journal-title":"Onkologie"},{"key":"10.1016\/j.ejso.2019.01.009_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/stem.200011","article-title":"ABC transporters as phenotypic markers and functional regulators of stem cells","volume":"20","author":"Bunting","year":"2002","journal-title":"Stem Cell"},{"issue":"4","key":"10.1016\/j.ejso.2019.01.009_bib19","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.7314\/APJCP.2016.17.4.2271","article-title":"5-Aminolevulinic acid fluorescence in detection of peritoneal metastases","volume":"17","author":"Yonemura","year":"2016","journal-title":"Asian Pac J Cancer Prev APJCP"},{"key":"10.1016\/j.ejso.2019.01.009_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0090-8258(91)90099-Q","article-title":"Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer","volume":"40","author":"Burghardt","year":"1991","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib21","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1200\/JCO.2009.25.3617","article-title":"Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials","volume":"28","author":"du Bois","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00432-015-1945-y","article-title":"The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer","volume":"141","author":"Bachmann","year":"2015","journal-title":"J\u00a0Canc Res Clin Oncol"},{"key":"10.1016\/j.ejso.2019.01.009_bib23","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.5500","article-title":"LION: lymphadenectomy in ovarian neoplasms\u2014a prospective randomized AGO study group led gynecologic cancer intergroup trial","volume":"35","author":"Harter","year":"2017","journal-title":"J\u00a0Clin Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319300095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319300095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:30:06Z","timestamp":1760059806000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319300095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0748798319300095"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.01.009","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}